Galectins as modulators of tumour progression

Galectins are a family of animal lectins with diverse biological activities. They function both extracellularly, by interacting with cell-surface and extracellular matrix glycoproteins and glycolipids, and intracellularly, by interacting with cytoplasmic and nuclear proteins to modulate signalling pathways. Current research indicates that galectins have important roles in cancer; they contribute to neoplastic transformation, tumour cell survival, angiogenesis and tumour metastasis. They can modulate the immune and inflammatory responses and might have a key role helping tumours to escape immune surveillance. How do the different members of the Galectin family contribute to these diverse aspects of tumour biology?

[1]  A. Karlsson,et al.  Galectins as inflammatory mediators , 2004, Glycoconjugate Journal.

[2]  J. Trapani Tumor-mediated apoptosis of cancer-specific T lymphocytes--reversing the "kiss of death"? , 2002, Cancer cell.

[3]  John L. Wang,et al.  Intracellular functions of galectins. , 2002, Biochimica et biophysica acta.

[4]  L. Baum,et al.  Presentation of Galectin-1 by Extracellular Matrix Triggers T Cell Death* , 2004, Journal of Biological Chemistry.

[5]  J. Ochieng,et al.  Extracellular functions of galectin-3 , 2004, Glycoconjugate Journal.

[6]  N. Tinari,et al.  Galectin‐3 overexpression protects from cell damage and death by influencing mitochondrial homeostasis , 2000, FEBS letters.

[7]  R. Lotan,et al.  Inhibition of N-(4-hydroxyphenyl)retinamide-Induced Apoptosis in Breast Cancer Cells by Galectin-3 , 2004, Cancer biology & therapy.

[8]  M. Hirashima,et al.  Human Ecalectin, a Variant of Human Galectin-9, Is a Novel Eosinophil Chemoattractant Produced by T Lymphocytes* , 1998, The Journal of Biological Chemistry.

[9]  J. Folkman Role of angiogenesis in tumor growth and metastasis. , 2002, Seminars in oncology.

[10]  S. Kaufman,et al.  Selective modulation of the interaction of alpha 7 beta 1 integrin with fibronectin and laminin by L-14 lectin during skeletal muscle differentiation. , 1994, Journal of cell science.

[11]  Kevin C. Haudek,et al.  Nucleocytoplasmic lectins. , 2004, Biochimica et biophysica acta.

[12]  Tak W. Mak,et al.  Pathways of apoptotic and non-apoptotic death in tumour cells , 2004, Nature Reviews Cancer.

[13]  R. Hughes Secretion of the galectin family of mammalian carbohydrate-binding proteins. , 1999, Biochimica et biophysica acta.

[14]  G. Rabinovich,et al.  Recombinant Galectin-1 and Its Genetic Delivery Suppress Collagen-Induced Arthritis via T Cell Apoptosis , 1999, The Journal of experimental medicine.

[15]  Stefano Iacobelli,et al.  Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response? , 2002, Trends in immunology.

[16]  Michael J. Davis,et al.  Shuttling of galectin-3 between the nucleus and cytoplasm. , 2002, Glycobiology.

[17]  T. Yoshii,et al.  CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis. , 2003, Cancer research.

[18]  J. Ochieng,et al.  Modulation of the biological functions of galectin-3 by matrix metalloproteinases. , 1998, Biochimica et biophysica acta.

[19]  J. L. Wang,et al.  Evidence for a role for galectin-1 in pre-mRNA splicing , 1997, Molecular and cellular biology.

[20]  G. Jarvis,et al.  Truncated galectin-3 inhibits tumor growth and metastasis in orthotopic nude mouse model of human breast cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[21]  S. Deutscher,et al.  Peptides specific to the galectin-3 carbohydrate recognition domain inhibit metastasis-associated cancer cell adhesion. , 2004, Carcinogenesis.

[22]  J. Rini,et al.  New animal lectin structures. , 1999, Current opinion in structural biology.

[23]  F. Poirier Roles of galectins in vivo. , 2002, Biochemical Society symposium.

[24]  Yusuke Nakamura,et al.  Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-α secretion in vitro , 2004, Nature.

[25]  S. Sidhu,et al.  Phylogenetic analysis of the vertebrate galectin family. , 2004, Molecular biology and evolution.

[26]  J. Ochieng,et al.  Regulation of cellular adhesion to extracellular matrix proteins by galectin-3. , 1998, Biochemical and biophysical research communications.

[27]  Y. Kloog,et al.  Galectin-1 Augments Ras Activation and Diverts Ras Signals to Raf-1 at the Expense of Phosphoinositide 3-Kinase* , 2002, The Journal of Biological Chemistry.

[28]  R. Hughes,et al.  Effects of the carbohydrate‐binding protein galectin‐3 on the invasiveness of human breast carcinoma cells , 1996, Journal of cellular physiology.

[29]  A. Hoeflich,et al.  Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures , 2001, Journal of Cancer Research and Clinical Oncology.

[30]  L. Yu,et al.  This information is current as Macrophages Chemoattractant for Monocytes and Human Galectin-3 Is a Novel , 2000 .

[31]  G. Rabinovich,et al.  The antimetastatic effect of a single low dose of cyclophosphamide involves modulation of galectin-1 and Bcl-2 expression , 2001, Cancer Immunology, Immunotherapy.

[32]  J. Hirabayashi,et al.  Involvement of CD2 and CD3 in galectin-1 induced signaling in human Jurkat T-cells. , 2000, Glycobiology.

[33]  R. Hughes Galectins as modulators of cell adhesion. , 2001, Biochimie.

[34]  加塩 裕美子 Galectin-9 induces apoptosis through calcium-calpain-caspase-1 pathway , 2003 .

[35]  H. Inohara,et al.  Bh1 (nwgr) Domain of Bcl-2 Family Galectin-3: a Novel Antiapoptotic Molecule with a Functional Updated Version Citing Articles E-mail Alerts Galectin-3: a Novel Antiapoptotic Molecule with a Functional Bh1 (nwgr) Domain of Bcl-2 Family' , 2022 .

[36]  J. Pollard Tumour-educated macrophages promote tumour progression and metastasis , 2004, Nature Reviews Cancer.

[37]  David A. Cheresh,et al.  Role of integrins in cell invasion and migration , 2002, Nature Reviews Cancer.

[38]  M. Huflejt,et al.  Galectin-4 in normal tissues and cancer , 2003, Glycoconjugate Journal.

[39]  Y. Kloog,et al.  Galectin-1 binds oncogenic H-Ras to mediate Ras membrane anchorage and cell transformation , 2001, Oncogene.

[40]  Richard D. Cummings,et al.  Galectins: A family of animal β-galactoside-binding lectins , 1994, Cell.

[41]  Xiaodong Wang,et al.  Galectin-1 induces nuclear translocation of endonuclease G in caspase- and cytochrome c-independent T cell death , 2004, Cell Death and Differentiation.

[42]  S. Barondes,et al.  Evidence for export of a muscle lectin from cytosol to extracellular matrix and for a novel secretory mechanism , 1990, The Journal of cell biology.

[43]  B. Wiedenmann,et al.  Human Galectin-2: Novel Inducer of T Cell Apoptosis with Distinct Profile of Caspase Activation1 , 2004, The Journal of Immunology.

[44]  A. Raz,et al.  Galectin-3 enhances cyclin D1 promoter activity through SP1 and a cAMP-responsive element in human breast epithelial cells , 2002, Oncogene.

[45]  Riyao Yang,et al.  Expression of galectin-3 modulates T-cell growth and apoptosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[46]  M. Matsuda,et al.  Galectin-12, an Adipose-expressed Galectin-like Molecule Possessing Apoptosis-inducing Activity* , 2001, The Journal of Biological Chemistry.

[47]  F. T. Liu,et al.  Galectins: A new family of regulators of inflammation , 2000 .

[48]  Timothy R Billiar,et al.  Role of galectin-3 in breast cancer metastasis: involvement of nitric oxide. , 2002, The American journal of pathology.

[49]  John L. Wang,et al.  Identification of galectin-3 as a factor in pre-mRNA splicing. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[50]  C. Bruni,et al.  Galectin genes: Regulation of expression , 2004, Glycoconjugate Journal.

[51]  Fu-Tong Liu,et al.  Suppression of Tumor Growth by Galectin-7 Gene Transfer , 2004, Cancer Research.

[52]  H. Pircher,et al.  Beta-galactoside-binding protein secreted by activated T cells inhibits antigen-induced proliferation of T cells. , 1998, European journal of immunology.

[53]  C. Uyttenhove,et al.  Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase , 2003, Nature Medicine.

[54]  M. Hirashima,et al.  Galectin-8 modulates neutrophil function via interaction with integrin alphaM. , 2003, Glycobiology.

[55]  K. Mishima,et al.  Expression of galectin‐1 mRNA correlates with the malignant potential of human gliomas and expression of antisense galectin‐1 inhibits the growth of 9 glioma cells , 2000, Journal of neuroscience research.

[56]  A. Hoeflich,et al.  Tumor galectinology: Insights into the complex network of a family of endogenous lectins , 2003, Glycoconjugate Journal.

[57]  Douglas N W Cooper,et al.  Galectinomics: finding themes in complexity. , 2002, Biochimica et biophysica acta.

[58]  R. Lotan,et al.  Differential regulation of constitutive and retinoic acid-induced galectin-1 gene transcription in murine embryonal carcinoma and myoblastic cells. , 2000, Biochimica et biophysica acta.

[59]  N. Mitsiades,et al.  Fas ligand expression in thyroid carcinomas: a potential mechanism of immune evasion. , 1999, The Journal of clinical endocrinology and metabolism.

[60]  Susanne Carlsson,et al.  Introduction to galectins , 1997, Glycoconjugate Journal.

[61]  C. Colnot,et al.  Maintenance of granulocyte numbers during acute peritonitis is defective in galectin‐3‐null mutant mice , 1998, Immunology.

[62]  J. Le Pennec,et al.  Human galectin-8 isoforms and cancer , 2004, Glycoconjugate Journal.

[63]  M. Hirashima,et al.  Galectin-8 modulates neutrophil function via interaction with integrin alphaM. , 2003, Glycobiology.

[64]  S. Tsuboi,et al.  Expression of a Specific Glycosyltransferase Enzyme Regulates T Cell Death Mediated by Galectin-1* , 2000, The Journal of Biological Chemistry.

[65]  O. Kalayci,et al.  Critical role for galectin-3 in airway inflammation and bronchial hyperresponsiveness in a murine model of asthma. , 2004, The American journal of pathology.

[66]  N. Sharon,et al.  History of lectins: from hemagglutinins to biological recognition molecules. , 2004, Glycobiology.

[67]  Haidong Dong,et al.  Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion , 2002, Nature Medicine.

[68]  A. D. Amo,et al.  Galectin-3 down-regulates IL-5 gene expression on different cell types. , 1998, Journal of immunology.

[69]  C. Aring,et al.  A CRITICAL REVIEW , 1939, Journal of neurology and psychiatry.

[70]  L. Mallucci,et al.  Cell cycle arrest and induction of apoptosis by β galactoside binding protein (βGBP) in human mammary cancer cells. A potential new approach to cancer control , 1999 .

[71]  M. Teitell,et al.  An anti-apoptotic role for galectin-3 in diffuse large B-cell lymphomas. , 2004, The American journal of pathology.

[72]  赤埴 詩朗 Galectin-3 : a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family , 2000 .

[73]  G. Rabinovich,et al.  Activated rat macrophages produce a galectin-1-like protein that induces apoptosis of T cells: biochemical and functional characterization. , 1998, Journal of immunology.

[74]  J. Hirabayashi,et al.  A novel biological activity for galectin-1: inhibition of leukocyte-endothelial cell interactions in experimental inflammation. , 2003, The American journal of pathology.

[75]  R. Kiss,et al.  Galectin‐1 Modulates Human Glioblastoma Cell Migration into the Brain Through Modifications to the Actin Cytoskeleton and Levels of Expression of Small GTPases , 2002, Journal of neuropathology and experimental neurology.

[76]  W. Song,et al.  Selective modulation of the interaction of α 7 β 1 integrin with fibronectin and laminin by L-14 lectin during skeletal muscle differentiation , 1996 .

[77]  M. Karin,et al.  Inhibition of NF-κB in cancer cells converts inflammation- induced tumor growth mediated by TNFα to TRAIL-mediated tumor regression , 2004 .

[78]  H. Ahmed,et al.  C-type lectins and galectins mediate innate and adaptive immune functions: their roles in the complement activation pathway. , 1999, Developmental and comparative immunology.

[79]  Y. Takenaka,et al.  Galectin-3, a Novel Binding Partner of β-Catenin , 2004, Cancer Research.

[80]  R. Liskamp,et al.  Wedgelike Glycodendrimers as Inhibitors of Binding of Mammalian Galectins to Glycoproteins, Lactose Maxiclusters, and Cell Surface Glycoconjugates , 2001, Chembiochem : a European journal of chemical biology.

[81]  G. Rabinovich,et al.  Molecular mechanisms implicated in galectin-1-induced apoptosis: activation of the AP-1 transcription factor and downregulation of Bcl-2 , 2000, Cell Death and Differentiation.

[82]  J. Dennis,et al.  Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation , 2001, Nature.

[83]  T. Yoshii,et al.  Nuclear Export of Phosphorylated Galectin-3 Regulates Its Antiapoptotic Activity in Response to Chemotherapeutic Drugs , 2004, Molecular and Cellular Biology.

[84]  R. Cummings,et al.  Dimeric Galectin-1 Induces Surface Exposure of Phosphatidylserine and Phagocytic Recognition of Leukocytes without Inducing Apoptosis* , 2003, Journal of Biological Chemistry.

[85]  K. Okuno,et al.  Role of galectin-3 in adenocarcinoma liver metastasis. , 2001, International journal of oncology.

[86]  T. Yoshii,et al.  Galectin-3 Phosphorylation Is Required for Its Anti-apoptotic Function and Cell Cycle Arrest* , 2002, The Journal of Biological Chemistry.

[87]  Fu-Tong Liu,et al.  Functions of galectins in cell adhesion and chemotaxis. , 2003, Methods in enzymology.

[88]  Sachiko Sato,et al.  Seeing strangers or announcing “danger”: Galectin-3 in two models of innate immunity , 2004, Glycoconjugate Journal.

[89]  V. Castronovo,et al.  Dual activities of galectin-3 in human prostate cancer: tumor suppression of nuclear galectin-3 vs tumor promotion of cytoplasmic galectin-3 , 2004, Oncogene.

[90]  J. Ochieng,et al.  Galectin-3 mediates the endocytosis of β-1 integrins by breast carcinoma cells , 2001 .

[91]  Y. Takenaka,et al.  Galectin-3 and metastasis , 2004, Glycoconjugate Journal.

[92]  N. Tinari,et al.  Galectin‐3 overexpression protects from apoptosis by improving cell adhesion properties , 2000, International journal of cancer.

[93]  S. Snapper,et al.  Induced reactivity of intestinal CD4(+) T cells with an epithelial cell lectin, galectin-4, contributes to exacerbation of intestinal inflammation. , 2004, Immunity.

[94]  Ariel,et al.  Specific inhibition of T‐cell adhesion to extracellular matrix and proinflammatory cytokine secretion by human recombinant galectin‐1 , 1999, Immunology.

[95]  J. Ochieng,et al.  Galectin‐3 regulates the adhesive interaction between breast carcinoma cells and elastin , 1999, Journal of cellular biochemistry.

[96]  R. Schreiber,et al.  The immunobiology of cancer immunosurveillance and immunoediting. , 2004, Immunity.

[97]  Y. Takenaka,et al.  Galectins and urological cancer , 2004, Journal of cellular biochemistry.

[98]  H. Gabius,et al.  Galectin-3 Precipitates as a Pentamer with Synthetic Multivalent Carbohydrates and Forms Heterogeneous Cross-linked Complexes* , 2004, Journal of Biological Chemistry.

[99]  L. A. Lewis,et al.  Galectin-1 Induces Partial TCR ζ-Chain Phosphorylation and Antagonizes Processive TCR Signal Transduction1 , 2000, The Journal of Immunology.

[100]  I Salmon,et al.  Galectin-8 expression decreases in cancer compared with normal and dysplastic human colon tissue and acts significantly on human colon cancer cell migration as a suppressor , 2002, Gut.

[101]  D. Gabrilovich,et al.  Tumor escape from immune response: mechanisms and targets of activity. , 2003, Current drug targets.

[102]  G. Rabinovich,et al.  Shedding light on the immunomodulatory properties of galectins: Novel regulators of innate and adaptive immune responses , 2004, Glycoconjugate Journal.

[103]  P. Stewart,et al.  Restricted receptor segregation into membrane microdomains occurs on human T cells during apoptosis induced by galectin-1. , 1999, Journal of immunology.

[104]  R.-Y. Yang,et al.  Galectins in cell growth and apoptosis , 2003, Cellular and Molecular Life Sciences CMLS.

[105]  G. Glinsky,et al.  MDA-MB-435 Human Breast Carcinoma Cell Homo- and Heterotypic Adhesion under Flow Conditions Is Mediated in Part by Thomsen-Friedenreich Antigen-Galectin-3 Interactions* , 2003, The Journal of Biological Chemistry.

[106]  Y. Kloog,et al.  Galectin-3 Augments K-Ras Activation and Triggers a Ras Signal That Attenuates ERK but Not Phosphoinositide 3-Kinase Activity* , 2004, Journal of Biological Chemistry.

[107]  R. Bresalier,et al.  Metastasis of human colon cancer is altered by modifying expression of the beta-galactoside-binding protein galectin 3. , 1998, Gastroenterology.

[108]  D. Green,et al.  Galectin-7 (PIG1) Exhibits Pro-apoptotic Function through JNK Activation and Mitochondrial Cytochrome cRelease* 210 , 2002, The Journal of Biological Chemistry.

[109]  A. Sarasin,et al.  Galectin-7 overexpression is associated with the apoptotic process in UVB-induced sunburn keratinocytes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[110]  E. Meeusen,et al.  Galectins in parasite infection and allergic inflammation , 2004, Glycoconjugate Journal.

[111]  H. Inohara,et al.  Down-regulation of galectin-3 suppresses tumorigenicity of human breast carcinoma cells. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[112]  T. Yoshii,et al.  Galectin-3 maintains the transformed phenotype of thyroid papillary carcinoma cells. , 2001, International journal of oncology.

[113]  T. Feizi Progress in deciphering the information content of the ‘glycome’ – a crescendo in the closing years of the millennium , 2000, Glycoconjugate Journal.

[114]  G. Rabinovich,et al.  Induction of allogenic T-cell hyporesponsiveness by galectin-1-mediated apoptotic and non-apoptotic mechanisms , 2002, Cell Death and Differentiation.

[115]  D. Pardoll,et al.  Does the immune system see tumors as foreign or self? , 2003, Annual review of immunology.

[116]  Jian Ni,et al.  Cell Cycle Regulation by Galectin-12, a New Member of the Galectin Superfamily* , 2001, The Journal of Biological Chemistry.

[117]  Mariano J. Alvarez,et al.  Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumor-immune privilege. , 2004, Cancer cell.

[118]  B. Lewis A Historical Overview , 1996 .

[119]  K. Pienta,et al.  Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium. , 2003, Cancer research.

[120]  A. Berchuck,et al.  Galectin-1 Accumulation in the Ovary Carcinoma Peritumoral Stroma Is Induced by Ovary Carcinoma Cells and Affects Both Cancer Cell Proliferation and Adhesion to Laminin-1 and Fibronectin , 2003, Laboratory Investigation.

[121]  A. Kumar,et al.  Developmental regulation, expression, and apoptotic potential of galectin-9, a beta-galactoside binding lectin. , 1997, The Journal of clinical investigation.

[122]  R. Lotan,et al.  Differential expression of endogenous galectin-1 and galectin-3 in human prostate cancer cell lines and effects of overexpressing galectin-1 on cell phenotype. , 1999, International journal of oncology.

[123]  A. Scaloni,et al.  Nuclear localization of Galectin-3 in transformed thyroid cells: a role in transcriptional regulation. , 2003, Biochemical and biophysical research communications.

[124]  J. Dennis,et al.  Regulation of Cytokine Receptors by Golgi N-Glycan Processing and Endocytosis , 2004, Science.

[125]  Toshihiko Oka,et al.  Oligosaccharide specificity of galectins: a search by frontal affinity chromatography. , 2002, Biochimica et biophysica acta.

[126]  J. L. Wang,et al.  Carbohydrate-binding protein 35. Isoelectric points of the polypeptide and a phosphorylated derivative. , 1990, The Journal of biological chemistry.

[127]  G. Rabinovich,et al.  Evidence of a role for galectin‐1 in acute inflammation , 2000, European journal of immunology.

[128]  L. Baum,et al.  Clusters, bundles, arrays and lattices: novel mechanisms for lectin-saccharide-mediated cellular interactions. , 2002, Current opinion in structural biology.

[129]  Isabelle Camby,et al.  Galectins and cancer. , 2002, Biochimica et biophysica acta.

[130]  L. Stephens,et al.  Effects of galectin‐3 expression on growth and tumorigenicity of the prostate cancer cell line LNCaP , 2002, The Prostate.

[131]  B. Geiger,et al.  Galectin-8 Functions as a Matricellular Modulator of Cell Adhesion* , 2001, The Journal of Biological Chemistry.

[132]  Yoshifumi Yamamoto,et al.  Malignant transformation of thyroid follicular cells by galectin-3. , 2003, Cancer letters.

[133]  V. Castronovo,et al.  Expression of galectins in cancer: A critical review , 2004, Glycoconjugate Journal.

[134]  Hua Yu,et al.  The STATs of cancer — new molecular targets come of age , 2004, Nature Reviews Cancer.

[135]  H Kaltner,et al.  Negative Regulation of Neuroblastoma Cell Growth by Carbohydrate-dependent Surface Binding of Galectin-1 and Functional Divergence from Galectin-3* , 2001, The Journal of Biological Chemistry.

[136]  W. Fung-Leung,et al.  Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses. , 2000, The American journal of pathology.

[137]  G. Rabinovich,et al.  Galectin-1 suppresses experimental colitis in mice. , 2003, Gastroenterology.

[138]  S. Barondes,et al.  L-29, a soluble lactose-binding lectin, is phosphorylated on serine 6 and serine 12 in vivo and by casein kinase I. , 1993, The Journal of biological chemistry.

[139]  M. Territo,et al.  Amelioration of graft versus host disease by galectin-1. , 2003, Clinical immunology.

[140]  L. O’Driscoll,et al.  Galectin-3 expression alters adhesion, motility and invasion in a lung cell line (DLKP), in vitro. , 2002, Anticancer research.

[141]  H. Gabius Animal lectins. , 1997, European journal of biochemistry.

[142]  R. Finley,et al.  Galectin-3 Translocates to the Perinuclear Membranes and Inhibits Cytochrome c Release from the Mitochondria , 2002, The Journal of Biological Chemistry.

[143]  R. Kiss,et al.  Upregulation of galectins‐1 and ‐3 in human colon cancer and their role in regulating cell migration , 2003, International journal of cancer.

[144]  F. Balkwill Cancer and the chemokine network , 2004, Nature Reviews Cancer.

[145]  A. Heck,et al.  Homodimeric galectin-7 (p53-induced gene 1) is a negative growth regulator for human neuroblastoma cells , 2003, Oncogene.

[146]  G. Rabinovich,et al.  Galectin-3 Mediates IL-4-Induced Survival and Differentiation of B Cells: Functional Cross-Talk and Implications during Trypanosoma cruzi Infection 1 , 2004, The Journal of Immunology.

[147]  L. Baum,et al.  Apoptosis of T cells mediated by galectin-1 , 1995, Nature.

[148]  K. Pienta,et al.  Galectin-3 induces endothelial cell morphogenesis and angiogenesis. , 2000, The American journal of pathology.

[149]  H. Erdjument-Bromage,et al.  Induction of Terminal Differentiation in Epithelial Cells Requires Polymerization of Hensin by Galectin 3 , 2000, The Journal of cell biology.

[150]  A. Raz,et al.  Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells. , 1999, Cancer research.